Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214

Ying Chen, Hui Du, Lewen Bao and Wenxin Liu
Cancer Biology & Medicine August 2018, 15 (3) 238-250; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0174
Ying Chen
1Department of Gynecologic Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lychenying2004{at}126.com
Hui Du
2Department of Obstetrics and Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lewen Bao
1Department of Gynecologic Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenxin Liu
1Department of Gynecologic Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 15 no. 3 238-250
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2017.0174

Published By 
Cancer Biology & Medicine
History 
  • Received November 28, 2017
  • Accepted April 12, 2018
  • Published online August 1, 2018.

Copyright & Usage 
Copyright: © 2018, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Ying Chen⇑1,*,
  2. Hui Du2,*,
  3. Lewen Bao1 and
  4. Wenxin Liu1
  1. 1Department of Gynecologic Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
  2. 2Department of Obstetrics and Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
  1. Correspondence to: Ying Chen E-mail: lychenying2004{at}126.com
View Full Text

Cited By...

  • 94 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 15 (3)
Cancer Biology & Medicine
Vol. 15, Issue 3
1 Aug 2018
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214
Ying Chen, Hui Du, Lewen Bao, Wenxin Liu
Cancer Biology & Medicine Aug 2018, 15 (3) 238-250; DOI: 10.20892/j.issn.2095-3941.2017.0174

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214
Ying Chen, Hui Du, Lewen Bao, Wenxin Liu
Cancer Biology & Medicine Aug 2018, 15 (3) 238-250; DOI: 10.20892/j.issn.2095-3941.2017.0174
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Material and methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Systematic identification and characterization of virus lncRNAs suggests extensive structural mimicry of host lncRNAs
  • Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro Model
  • PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance
  • The Role of lncRNA PVT1 and hsa-miR-30a-3p in the Development of Gastric Cancer
  • LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA
  • Google Scholar

More in this TOC Section

  • Migrasome-propagated ITGβ3-TGFβ1 circuit orchestrates breast cancer brain metastasis by reprogramming the microglial niche
  • Myeloid cell reprogramming combined with zoledronic acid effectively suppresses bone metastasis
  • Exosomal EPHA2 transfers metastatic potential by stabilizing TGF-βRI and activating the TGF-β/SMAD3 signaling pathway in breast cancer
Show more Original Article

Similar Articles

Keywords

  • Long non-coding RNA
  • PVT1
  • Ovarian cancer
  • miR-214

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire